These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35113266)

  • 21. Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis.
    Singer A; McClung MR; Tran O; Morrow CD; Goldstein S; Kagan R; McDermott M; Yehoshua A
    Arch Osteoporos; 2023 Mar; 18(1):42. PubMed ID: 36905559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic Fragility Fractures: An Opportunity to Improve the Undertreatment of Osteoporosis.
    Smith CT; Barton DW; Piple AS; Carmouche JJ
    J Bone Joint Surg Am; 2021 Feb; 103(3):213-218. PubMed ID: 33269895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of missed opportunities for secondary fracture prevention in a regional general hospital setting in Singapore.
    Gani L; Reddy SK; Alsuwaigh R; Khoo J; King TFJ
    Arch Osteoporos; 2017 Dec; 12(1):60. PubMed ID: 28656564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis.
    Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B
    J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
    Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
    Bone; 2023 Jan; 166():116605. PubMed ID: 36347433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries.
    Yusuf AA; Matlon TJ; Grauer A; Barron R; Chandler D; Peng Y
    Arch Osteoporos; 2016 Dec; 11(1):31. PubMed ID: 27696099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world bone turnover marker use: impact on treatment decisions and fracture.
    Lane NE; Saag K; O'Neill TJ; Manion M; Shah R; Klause U; Eastell R
    Osteoporos Int; 2021 May; 32(5):831-840. PubMed ID: 33236195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Belhassen M; Confavreux CB; Cortet B; Lamezec L; Ginoux M; Van Ganse E
    Osteoporos Int; 2017 Mar; 28(3):853-862. PubMed ID: 27766368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
    Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H
    Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
    Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
    Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the osteoporosis treatment gap after fragility hip fracture at a Tertiary University Medical Center in Thailand.
    Mahaisavariya C; Vanitcharoenkul E; Kitcharanant N; Chotiyarnwong P; Unnanuntana A
    BMC Geriatr; 2023 Feb; 23(1):70. PubMed ID: 36737708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The yawning gap between osteoporosis diagnosis and treatment after a fragility fracture in Mexico.
    Macías-Hernández SI; Degollado-Rodríguez MM; Maldonado-Sánchez H; de León AO; Coronado-Zarco R; Nava-Bringas TI; Ramírez-Pérez E; Cruz-Medina E; Espinosa-Morales R; Morones-Alba JD
    Arch Osteoporos; 2021 Apr; 16(1):59. PubMed ID: 33813681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008.
    McGowan B; Bennett K; Casey MC; Doherty J; Silke C; Whelan B
    Ir J Med Sci; 2013 Dec; 182(4):601-8. PubMed ID: 23483361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.
    Sato M; Ye W; Sugihara T; Isaka Y
    BMC Musculoskelet Disord; 2016 Nov; 17(1):489. PubMed ID: 27887655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study.
    Ross BJ; Ross AJ; Lee OC; Waters TL; Familia MM; Sherman WF
    Osteoporos Int; 2022 Sep; 33(9):1999-2010. PubMed ID: 35670832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study.
    Ljunggren Ö; Barrett A; Stoykov I; Langdahl BL; Lems WF; Walsh JB; Fahrleitner-Pammer A; Rajzbaum G; Jakob F; Karras D; Marin F
    BMC Musculoskelet Disord; 2013 Aug; 14():251. PubMed ID: 23968239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment for older men with fractures.
    Shepherd AJ; Cass AR; Ray LA; Tan A; Wilkinson GS
    Osteoporos Int; 2012 Mar; 23(3):1041-51. PubMed ID: 21811867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoporosis treatment rate following hip fracture in a community hospital.
    Khan AA; AbuAlrob H; Tariq F; Tauqir M; Zalzal P; M'Hiri I; Khan M; Ginty M; Weening B
    Arch Osteoporos; 2021 Jan; 16(1):8. PubMed ID: 33409668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rates of osteoporosis screening and treatment following vertebral fracture.
    Barton DW; Behrend CJ; Carmouche JJ
    Spine J; 2019 Mar; 19(3):411-417. PubMed ID: 30142455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.